Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria.
Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB.
Malkin E, et al. Among authors: diouf a.
PLoS Clin Trials. 2007;2(4):e12. doi: 10.1371/journal.pctr.0020012. Epub 2007 Apr 6.
PLoS Clin Trials. 2007.
PMID: 17415408
Free PMC article.